newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Announces Speakers for Virtual R&D Day Taking Place on June 8th

Company to present new preclinical data in myotonic dystrophy type 1 to support a path to enter the clinic in 2022, as well as provide updates on the Huntington's disease program and unveil a new oncology program targeting high-value genetic driver muta